175858-10-3 Usage
Description
2,6-Dibromoquinoxaline is a heterocyclic organic compound characterized by a quinoxaline core with two bromine atoms at the 2 and 6 positions, having the molecular formula C8H4Br2N2. It is widely recognized for its role as a building block in organic synthesis and pharmaceutical research, as well as for its potential as an antimicrobial agent.
Uses
Used in Pharmaceutical Research and Development:
2,6-Dibromoquinoxaline is used as a key intermediate in the synthesis of various pharmaceutical drugs and agrochemicals. Its unique structure and reactivity make it a valuable component in the development of new drug candidates with diverse therapeutic applications.
Used in Antimicrobial Applications:
2,6-Dibromoquinoxaline is used as an antimicrobial agent for its potential antibacterial and antifungal properties. It has been studied for its ability to inhibit the growth of various pathogenic microorganisms, making it a promising candidate for the development of new antimicrobial agents to combat drug-resistant infections.
Used in Medicinal Chemistry Research:
2,6-Dibromoquinoxaline serves as a research tool in the field of medicinal chemistry, particularly in the discovery and optimization of new drug candidates. Its versatile chemical properties allow for the exploration of various chemical modifications and the investigation of structure-activity relationships, facilitating the advancement of novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 175858-10-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,8,5 and 8 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 175858-10:
(8*1)+(7*7)+(6*5)+(5*8)+(4*5)+(3*8)+(2*1)+(1*0)=173
173 % 10 = 3
So 175858-10-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H4Br2N2/c9-5-1-2-6-7(3-5)11-4-8(10)12-6/h1-4H
175858-10-3Relevant articles and documents
METALLOENZYME INHIBITOR COMPOUNDS
-
Page/Page column 31-32, (2013/02/28)
The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
